Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 0R13.L
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 23.91 1.33 1.08
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -40.18 5.06 8.47
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 6.89 16.85 15.76
Cash 2.01 1.44 1.41
Capex 54.38 -0.19 -0.42
Free Cash Flow 63.12 0.89 0.55
Revenue -1.13 6.18 6.25
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 7.38 0.46 0.43
Operating Margin 43.46 0.20 0.14
ROA 48.28 0.03 0.02
ROE 39.28 0.06 0.04
ROIC 43.17 0.04 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 0R13.L is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 0R13.L is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 0R13.L is permitted for members.